Who We Insure
Clinical Trial Insurance for Sponsors and CROs: Participant Injury, Site Requirements and Protocol Errors
Clinical trial insurance exists because a study asks people to accept a risk on behalf of a product that is not yet proven. For sponsors and contract research organizations, the main exposure is bodily injury to a participant — the adverse event the consent form warned about and the one it did not — followed closely by the certificate requirements that every site, ethics committee, and country imposes before the first participant is enrolled.
Why clinical trial sponsors & CROs carry specialized insurance
The buying decision is forced rather than chosen. Institutional review boards and site contracts require evidence of sponsor coverage, many countries require locally admitted policies at mandated limits, and CRO master service agreements allocate protocol and data errors to the CRO with professional-liability requirements attached. A biotech can raise its Series A without a trial policy; it cannot dose its first participant without one. This guide covers clinical trial liability, products liability, CRO professional liability, cyber for participant data, and D&O, how site and country requirements shape the program, and what underwriters ask about the protocol, the population, and the investigational product.
Who this guide is for
Written for biotech, pharmaceutical, and medical-device sponsors preparing to run human studies, and for the contract research organizations and site networks that run them. Sponsors moving from preclinical work into first-in-human, Phase 1, or later-phase trials; Full-service and functional CROs, site management organizations, and specialty providers such as central labs and imaging cores; Device companies running pivotal or post-market studies; Not for eClinical software vendors, whose exposure is financial rather than bodily injury — see the clinical trial software guide below.
The risk profile of a clinical trial sponsor or CRO
Trial risk is concentrated in a small number of high-severity events, surrounded by a dense set of contractual and regulatory obligations that decide who pays when one occurs. Key exposures: Participant injury or death attributed to the investigational product, a procedure, or a protocol deviation; Claims that informed consent did not adequately disclose a risk that later materialized; Site- and country-mandated coverage gaps: a study starting in a country where the sponsor's global policy is not admitted or its limits are below the local requirement; CRO protocol, monitoring, or data-management errors that compromise a study and trigger indemnity claims from the sponsor; Breaches of participant health data held by the sponsor, the CRO, or their vendors; Investor and securities claims when a trial fails or is paused and disclosures are second-guessed.
Clinical Trial Liability for clinical trial sponsors & CROs
The core policy: it covers the sponsor's legal liability for bodily injury to participants arising from the study, usually on a per-protocol basis, and funds the no-fault medical expense obligations many countries and consent forms impose. It is written to respond in the jurisdictions where the study enrolls, which is why country-by-country placement matters. Typically responds to: participant bodily-injury claims and associated defense costs; no-fault medical expenses where required by local law or the protocol; locally admitted policies and certificates for each country and site.
Products Liability for clinical trial sponsors & CROs
Covers injury claims arising from the investigational product itself, including named-patient or compassionate-use programs that fall outside the trial policy, and becomes the main liability policy once a product is approved and sold.
CRO Professional Liability (E&O) for clinical trial sponsors & CROs
For CROs, the policy that responds when a sponsor alleges monitoring, protocol, pharmacovigilance, or data-management errors damaged the study. Sponsors require it in master service agreements, and the wording should follow the indemnities those agreements contain. Typically responds to: sponsor claims for financial loss from protocol or data errors; defense of regulatory-inspection follow-on claims; contingent bodily injury where the CRO form grants it.
Cyber & Privacy Liability for clinical trial sponsors & CROs
Participant records, adverse-event reports, and unblinded data sit across sponsors, CROs, sites, and vendors. Cyber funds breach response and regulatory defense and covers the business-interruption cost of a locked trial database during an active study.
Directors & Officers (D&O) for clinical trial sponsors & CROs
Trial results move valuations, and investors scrutinize how results and pauses were disclosed. D&O protects the board and officers from investor and regulatory claims; for sponsors heading toward public markets, the tower is built around trial-readout disclosure risk.
Contract and certificate requirements
Site clinical trial agreements and IRB submissions require certificates evidencing sponsor coverage, often with the protocol named and the site added as an additional insured. Country requirements vary widely: several European and Asian jurisdictions mandate locally admitted policies at specified per-participant and aggregate limits, and some require coverage to extend years beyond study completion. A global policy with local placements issued per country is the usual structure. CRO master service agreements allocate protocol and data errors to the CRO with professional liability requirements attached, while sponsors retain product and injury liability. Have your advisor read both the indemnity grid and the insurance exhibit; mismatches between who indemnifies and who is insured are the commonest gap in this category.
What coverage costs
Trial liability pricing is driven by the protocol: phase, therapeutic area, number of participants, population vulnerability, the countries involved, the route of administration, and the investigational product's known safety profile. First-in-human oncology studies and studies in pediatric or critically ill populations sit at the high end; late-phase studies of well-characterized products sit lower. CRO E&O and sponsor D&O price on revenue or funding, claims history, and the quality system behind the work. Participant data raises cyber severity, and IBM's Cost of a Data Breach Report 2026 put the global average breach cost at $4.99 million. Limits usually follow the strictest country or site requirement in the program rather than a general rule of thumb.
What underwriters will ask for
Underwriters price the protocol, so the submission is largely the study documents. Have ready: Protocol synopsis, phase, therapeutic area, enrollment target, and study duration; Investigator's brochure or safety summary for the investigational product; Countries and sites, with any locally mandated limits or wording; Informed consent form and the injury-compensation language it contains; For CROs: service lines, quality system, inspection history, and largest sponsor contracts; Data-protection controls across sponsor, CRO, and vendor systems.
Illustrative example: The serious adverse event
A participant in a Phase 2 study is hospitalized with an organ injury that investigators attribute to the study drug. The participant's family retains counsel and brings claims against the sponsor and the site, alleging the consent form understated the risk. Clinical trial liability defends the sponsor, pays the no-fault medical expenses the consent form promised, and responds to the injury claim within its limits. The site looks to its additional insured status under the sponsor's policy, which is exactly what the clinical trial agreement required.
Illustrative example: The country without a certificate
A sponsor expands enrollment to a new country to hit its timeline. The ethics committee refuses to approve the site because the sponsor's global policy is not admitted locally and the certificate does not show the mandated limits. Enrollment slips by a quarter. This is a placement failure rather than a claim: a locally admitted policy issued through the global program's network, with the protocol-specific certificate the committee needs, resolves it. Building the country list into the program before expansion avoids the delay entirely.
Illustrative example: The monitoring error
A CRO's monitors miss a pattern of dosing deviations at two sites. The sponsor discovers it during a database lock, excludes the data, and demands the cost of extended enrollment under the indemnity in the master service agreement. The CRO's professional liability policy defends the indemnity claim and pays covered damages; the contractual-liability wording and the agreement's liability cap determine how much of the sponsor's loss is recoverable.
How much does clinical trial insurance cost?
It is priced per protocol, so there is no standard figure. Phase, therapeutic area, enrollment size, population, countries, and the product's safety profile drive it, and country-mandated limits often set the floor. A first-in-human study in a vulnerable population will cost a multiple of a late-phase study of a well-characterized product.
Is clinical trial insurance legally required?
In many countries, yes: sponsors must show locally admitted coverage at mandated limits before a study is approved. In the United States it is required in practice rather than by statute, because IRBs, sites, and clinical trial agreements demand certificates before enrollment begins.
What is the difference between clinical trial liability and products liability?
Clinical trial liability covers participant injury during the study, including no-fault medical expenses where required. Products liability covers injury from the product outside the trial, including expanded-access programs and commercial sale after approval. Sponsors usually need both as the product matures.
Does a CRO need its own clinical trial insurance?
Usually not for participant injury, which stays with the sponsor. A CRO needs professional liability for protocol, monitoring, and data errors, plus cyber and general liability, and it should confirm it is named where the sponsor's trial policy allows.
Does the sponsor's policy cover the trial sites?
Sites are commonly added as additional insureds for claims arising from the study, but their own medical malpractice remains theirs. The clinical trial agreement's indemnity grid shows who is responsible for what; the certificate should match it.
Will a failed or paused trial trigger a D&O claim?
It can, particularly for companies with outside investors or public shareholders. Claims usually allege that results, enrollment problems, or regulatory feedback were disclosed late or incompletely. D&O coverage and disciplined disclosure practice are the two defenses.
Caveats and common gaps
Country requirements change, and admitted-policy rules, mandated limits, and post-study coverage periods differ by jurisdiction. Consent-form compensation language can create obligations broader than the policy. Verify each country's requirements with your advisor at protocol finalization and again before any expansion.
Related guides
Biotech and life sciences industry overview — the industry-level program; trial liability is a separate buying trigger covered here · Insurance for Clinical Trial Software Companies — the eClinical vendors whose exposure is financial rather than participant injury · Insurance for Healthtech Companies · Insurance for Medical Device Companies — device studies and the products program that follows clearance · Insurance for Genetic Testing & Diagnostics Companies — laboratory and diagnostics partners in trial and companion-diagnostic work · D&O insurance for startups · Startup insurance overview · Cyber liability coverage
Frequently asked questions
How much does clinical trial insurance cost?
It is priced per protocol, so there is no standard figure. Phase, therapeutic area, enrollment size, population, countries, and the product's safety profile drive it, and country-mandated limits often set the floor. A first-in-human study in a vulnerable population will cost a multiple of a late-phase study of a well-characterized product.
Is clinical trial insurance legally required?
In many countries, yes: sponsors must show locally admitted coverage at mandated limits before a study is approved. In the United States it is required in practice rather than by statute, because IRBs, sites, and clinical trial agreements demand certificates before enrollment begins.
What is the difference between clinical trial liability and products liability?
Clinical trial liability covers participant injury during the study, including no-fault medical expenses where required. Products liability covers injury from the product outside the trial, including expanded-access programs and commercial sale after approval. Sponsors usually need both as the product matures.
Does a CRO need its own clinical trial insurance?
Usually not for participant injury, which stays with the sponsor. A CRO needs professional liability for protocol, monitoring, and data errors, plus cyber and general liability, and it should confirm it is named where the sponsor's trial policy allows.
Does the sponsor's policy cover the trial sites?
Sites are commonly added as additional insureds for claims arising from the study, but their own medical malpractice remains theirs. The clinical trial agreement's indemnity grid shows who is responsible for what; the certificate should match it.
Will a failed or paused trial trigger a D&O claim?
It can, particularly for companies with outside investors or public shareholders. Claims usually allege that results, enrollment problems, or regulatory feedback were disclosed late or incompletely. D&O coverage and disciplined disclosure practice are the two defenses.
This material is general educational information, not legal, tax, or insurance advice. Coverage availability, policy terms, and regulatory requirements vary by state, carrier, and applicant.